Title:
CIIP - UK Multisector - BT-XC-UTI: Biofilm Inhibitors for Urinary Tract Infections
Agreement Number:
1036319
Agreement Value:
$200,000.00
Agreement Date:
Sep 29, 2025 - Aug 28, 2026
Description:
The aim of the CIIP - UK Multisector - BT-XC-UTI project is to discover a new medicine to treat urinary tract infections. It is a collaboration between a Canadian company (IntelliSyn) with expertise in chemistry and a British company with expertise in biology (BioTryp). BioTryp has identified a bacterial protein that plays a key role in infection. IntelliSyn will design new therapeutic agents that inhibit this protein, and BioTryp will quantify the extent of inhibition in their biological assays. This iterative optimization cycle will also include drug elimination and safety optimization such that a safe, oral medicine to cure urinary tract infections can be identified.
Organization:
National Research Council Canada
Expected Results:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Location:
Saint-Laurent, Quebec, CA H4R 2P1
Reference Number:
172-2025-2026-Q3-1036319
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
807804687
Recipient Type:
For-profit organization
Recipient's Operating Name:
X-Chem Inc.
Recipient's Legal Name:
IntelliSyn Pharma Inc.
Federal Riding Name:
Saint-Laurent
Federal Riding Number:
24068
Program:
Canadian International Innovation Program
Program Purpose:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Coverage:
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access.